The Venture Codex

Participated · Series B · Nov 2025

Founded in 2020 by KAIST aerospace engineering alumnus Seung-Hyun Yoon, ADRO is an aerotech company that designs and sells aerodynamic body-kits for 12 car brands, including Tesla, BMW, Toyota and Porsche. Its 230+ SKUs not only change styling but also reduce drag and increase downforce; a real-world test on a Tesla Model Y demonstrated a 4.1 % drag reduction and a 4.6 % energy-efficiency gain. Roughly 90 % of the firm’s sales come from overseas, spanning 21 countries, with U.S. revenue tripling from ₩1.8 billion in 2023 to ₩5.2 billion in 2024. Consolidated revenue reached about ₩11 billion in 2024, up 93 % year-on-year, and the company reported ₩6.5 billion for the first half of 2025, a 46 % increase over the prior-year period. ADRO is also building AOX (Aerodynamic Optimization eXperience), a cloud-based, no-code AI simulation tool that promises CFD-level analysis in minutes; beta launch is planned for CES 2026. Partnerships with HP and AWS for AOX’s cloud infrastructure are under discussion. Proceeds from the latest funding will support new product development, U.S. offline center build-out, a German subsidiary, and continued AOX development.

Participated · Equity · Aug 2024

ADEL develops therapeutics targeting central nervous system disorders and advances antibody candidates through clinical development. Its notable programs include ADEL-Y01, a tau antibody candidate that was licensed out to Sanofi in a deal valued up to $1.04 billion with an $80 million non-refundable upfront payment. The company is advancing follow-on candidates ADEL-Y04 (ApoE4-targeting antibody) and ADEL-Y03 (β2-microglobulin-targeting antibody) and aims to accelerate their clinical timelines. ADEL intends to strengthen partnerships with domestic and international CNS specialists and further develop proprietary technology platforms. The company cites global business achievements and investor support as validation of its pipeline value. Management plans to complete a KOSDAQ technology special listing within the year and deploy the newly secured funds to deliver early pipeline development results.

Led · Series A · Jul 2024

JLT develops AI-integrated welding automation and integrated inspection systems aimed at improving quality, simplifying processes, cutting costs, and boosting productivity. The company supplies automation equipment for core EV and ship components and has deployed solutions with customers including Hyundai Motors, LG Magna, Semes, and Hyundai Robotics. JLT is in its fifth year, has surpassed KRW 10 billion in sales, and reports sustainable operating profits. It has extended operations to facilities in North America and Eastern Europe and is preparing for significant international expansion by 2025. With the new funding, JLT plans to advance its welding automation and integrated inspection products and to expand its market presence beyond automotive and shipbuilding into construction and broader industrial fields. Founded in 2019, 제이엘티 develops welding automation equipment and integrated solutions. Its technology performs real-time welding inspection, tracks weld lines, and digitizes weld data to optimize welding quality. The company supplies equipment and solutions to customers including LG마그나, 세메스, and 현대로보틱스. 제이엘티 is working with 한국생산기술연구원 on an integrated welding solution development project to advance its technology. It has expanded development into ship welding following a PoC with 현대중공업 and plans to further enhance its integrated automation and inspection systems using new funding. 제이엘티 aims to record more than 100억원 in sales this year, continuing growth from the prior year.

Participated · Series A · Dec 2023

GenGenAI develops AI synthetic-data solutions using proprietary domain-specialized generative models to create, transform, and synthesize training data. Its commercial offerings include ‘GenGenData’ (custom synthetic datasets) and ‘GenGenVision’ (vision AI delivered via SDK/API), and it is developing a self-serve ‘GenGenStudio’ platform. The company says its technology reduces time and cost for data collection by converting existing data, synthesizing variants, or generating wholly new data. GenGenAI plans to expand into mobility, defense, and healthcare where labeled training data is in high demand. Founded in January 2022, the company recently raised a pre-Series A and has total disclosed funding of ₩5.3B to date. It was also selected for Korea’s Scale-up TIPS program and will receive up to ₩1.2B in R&D support over three years.

Participated · Series A · Dec 2023

PLCO, operated by QMIT, is a sports intelligence platform that aggregates match data, physical measurements, training load, and condition data to support data-driven player development and team performance management. The platform has been used cumulatively by about 1,500 coaches and 12,000 players and is deployed at major Korean professional clubs including Jeonbuk Hyundai Motors, Suwon Samsung Bluewings, Suwon FC, and SSG Landers. PLCO has expanded beyond soccer into baseball, basketball, volleyball, and athletics, and has extended its offerings into solutions such as PLCO Coach, an offline performance center called PLCO Gym, and a sports nutrition business, PLCO Nutrition. The company cites on-field impact after adoption by Jeonbuk Hyundai, which subsequently won K League 1 and reached the Korea Cup final. PLCO is pursuing international expansion, advancing collaborations with leagues in Japan and Vietnam and preparing to enter the Japan and Southeast Asia markets. Within the year it plans to launch an IDP solution that uses DNA and measurement data to analyze nutrition, performance capacity, injury risk, and mental factors to deliver individualized growth roadmaps.